--- title: "Restructuring Global Liquidity: Structural Opportunities from US Defense to Yield-Bearing ETFs" type: "News" locale: "en" url: "https://longbridge.com/en/news/293448921.md" description: "This roundup examines ten disparate assets across fixed income, defense, and biotechnology. As shifting macroeconomic policies reshape global liquidity, capital is rotating into inflation hedges and strategic supply chain infrastructure, highlighting a deep divergence in sector fundamentals." datetime: "2026-07-22T09:18:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293448921.md) - [en](https://longbridge.com/en/news/293448921.md) - [zh-HK](https://longbridge.com/zh-HK/news/293448921.md) --- # Restructuring Global Liquidity: Structural Opportunities from US Defense to Yield-Bearing ETFs Against the backdrop of escalating geopolitical fragmentation and shifting monetary paradigms, global capital is selectively migrating toward resilient margins of the US market. The latest trading sessions sent the strongest signal yet that investors are simultaneously seeking absolute yield and idiosyncratic growth catalysts, deliberately bypassing traditional mega-caps in favor of specialized exposure. The divergence at the heart of this eclectic basket of ten equities and ETFs highlights a profound macroeconomic tension. While policymakers navigate a meeting-by-meeting situation regarding interest rate paths, institutional flows are aggressively pricing in worst-case supply chain disruptions alongside persistent inflation. The downside risks to this rotation stem largely from regulatory spillovers and abrupt currency fluctuations that could severely penalize highly leveraged balance sheets. **Defense and Resources: Rewiring Global Supply Chains** In the defense sector, Leonardo DRS (DRS.US) has garnered robust momentum year-to-date, remaining insulated from cyclical consumer weakness. The defense technology firm secured multiple contracts under the Missile Defense Agency's SHIELD initiative with a massive ceiling of USD 151B, alongside a recent procurement agreement for over 50,000 thermal imaging cameras in July 2026. This underpins a structural shift in international military spending. Similarly, Rare Earths Americas (REA.US) has held steady since raising roughly USD 63M in its IPO. By advancing its Alpha and Constellation projects across the US and Brazil, the exploration-stage mining company sits at the nexus of the West's strategic push to decouple critical mineral supply chains from overseas dominance. **Defensive Assets and Cross-Border Finance** As 7 of the 19 policymakers penciled in fewer cuts in recent macroeconomic projections, income-generating vehicles have reclaimed the spotlight. The Eaton Vance Income Opportunities ETF (XAGG.US), boasting total net assets of USD 1.3B, is trading with notable stability, offering diversified fixed-income exposure to a wary investor base. The Defiance Gold Enhanced Options Income ETF (GOLI.US) is likewise seeing steady price action, acting as a sophisticated hedge against sticky inflation. In the physical asset space, Essex Property Trust (ESS.US) continues to outperform its broader sector. The S&P 500 REIT, which issued a 2026 core FFO guidance midpoint of USD 15.94 per share, executed over USD 700M in California apartment transactions last year, capturing resilient cross-border demand for premium West Coast real estate. On the flip side of cross-border finance, Yiren Digital (YRD.US) is facing immense pressure this quarter. The Asian AI financial services platform posted a staggering 41% plunge in Q1 2026 total net revenue to RMB 915.1M, swinging to a net loss of RMB 493.5M—a stark reminder of the fragile consumer health in emerging markets. **Clinical Frontiers and Infrastructure Hurdles** Companies relying on extensive capital expenditure and international regulatory approvals are experiencing a starkly polarized environment. Butterfly Network (BFLY.US) has rebounded recently following a solid Q1 2026 report where revenue reached USD 26.5M. The firm is actively scaling its semiconductor-based ultrasound technology across global home care settings. Meanwhile, clinical-stage biotechs remain susceptible to sudden risk-off sentiment. Relay Therapeutics (RLAY.US) has been volatile despite encouraging Phase 2 trial results where its therapy demonstrated a 60% volume response rate in 20 patients. Caribou Biosciences (CRBU.US) has largely traded sideways, though it secured FDA Fast Track designation for its CB-012 therapy targeting relapsed acute myeloid leukemia in July 2026. Lastly, Crown Electrokinetics (CRKN.US) underscores the severe penalties for missing the compliance window. While it announced a USD 100M multi-year fiber contract and grew Q1 2025 revenue to USD 2.8M, the company was forced to voluntarily delist from the Nasdaq, stranding its equity amid a fierce infrastructure race. Looking ahead, the trajectory for these disparate assets will depend heavily on whether inflation metrics compel central banks to maintain restrictive conditions. With multiple global elections and tariff reviews on the horizon, market participants should brace for heightened cross-border volatility. _This article does not constitute investment advice._ ### Related Stocks - [DRS.US](https://longbridge.com/en/quote/DRS.US.md) - [REA.US](https://longbridge.com/en/quote/REA.US.md) - [ESS.US](https://longbridge.com/en/quote/ESS.US.md) - [YRD.US](https://longbridge.com/en/quote/YRD.US.md) - [BFLY.US](https://longbridge.com/en/quote/BFLY.US.md) - [RLAY.US](https://longbridge.com/en/quote/RLAY.US.md) - [CRBU.US](https://longbridge.com/en/quote/CRBU.US.md) - [CRKN.US](https://longbridge.com/en/quote/CRKN.US.md) ## Related News & Research - [Butterfly Network director Jonathan M. Rothberg disposes of 659,913 common shares worth $4.27 million](https://longbridge.com/en/news/293797197.md) - [Butterfly Network director, 10% owner Jonathan M. Rothberg reports $20.76 million share sale](https://longbridge.com/en/news/293396713.md) - [Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?](https://longbridge.com/en/news/279289074.md) - [Essex Property Trust (NYSE:ESS) Coverage Initiated by Analysts at Sanford C. Bernstein](https://longbridge.com/en/news/290978192.md) - [Yiren Digital signs warrant deal to pursue control of AI entertainment platform](https://longbridge.com/en/news/292057677.md)